Tacrolimus for treatment of gout in renal transplantation: Two case reports and review of the literature

Transplantation

Volumn 72, Issue 10, 2001, Pages 1703-1705

  Pilmore, Helen L ^a   Faire, Bridget ^a   Dittmer, Ian ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AZATHIOPRINE; CALCINEURIN INHIBITOR; COLCHICINE; CYCLOSPORIN; DILTIAZEM; FUROSEMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; QUINAPRIL; STEROID; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GOUT; HUMAN; HYPERURICEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035960585     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200111270-00024     Document Type: Article

References (10)

1. Renal transplant-associated hyperuricemia and gout
2. Hyperuricemia and gout in renal allograft recipients
3. Japanese multi-center studies of FK 506 in renal transplantation
4. Origin and extrarenal elimination of uric acid in man
5. Evaluation of the renal mechanisms for urate homeostasis in uremic patients by probenecid and pyrazinamide test
6. The incidence of gout in renal transplant recipients
7. The mechanism of hyper-uricemia in cyclosporine-treated renal transplant recipients
8. Cyclosporine inhibits renal uric acid transport in renal transplants not in children treated for nephrotic syndrome
9. Renal handling of uric acid under cyclosporine treatment
10. Cyclosporine-induced hyperuricemia and gout